Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Rating) had its price target raised by equities researchers at Citigroup from $32.00 to $33.00 in a report issued on Tuesday, Stock Target Advisor reports. The firm presently has a “buy” rating on the stock. Citigroup’s price target suggests a potential upside of 145.17% from the stock’s current price. Amylyx […]
Equities research analysts predict that Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) will post ($0.90) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Amylyx Pharmaceuticals’ earnings. The lowest EPS estimate is ($0.96) and the highest is ($0.84). The business is expected to issue its next […]
Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Rating) was upgraded by analysts at Citigroup to a “buy” rating in a note issued to investors on Monday, Stock Target Advisor reports. The firm presently has a $32.00 target price on the stock. Citigroup’s price target suggests a potential upside of 160.80% from the stock’s previous close. NASDAQ:AMLX traded […]
Equities researchers at Citigroup started coverage on shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Rating) in a research report issued on Wednesday, Stock Target Advisor reports. The brokerage set a “buy” rating and a $21.00 price target on the stock. Citigroup’s target price would indicate a potential upside of 148.52% from the company’s previous close. […]
Equities analysts expect Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) to post ($0.75) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Amylyx Pharmaceuticals’ earnings, with the lowest EPS estimate coming in at ($0.81) and the highest estimate coming in at ($0.68). The company is […]